Rick E Winningham
2022 - Theravance Biopharma
In 2022, Rick E Winningham earned a total compensation of $6.3M as Chief Executive Officer at Theravance Biopharma.
Compensation breakdown
| Non-Equity Incentive Plan | $722,727 |
|---|---|
| Option Awards | $2,756,847 |
| Salary | $1,047,431 |
| Stock Awards | $1,740,800 |
| Other | $5,099 |
| Total | $6,272,904 |
Winningham received $2.8M in option awards, accounting for 44% of the total pay in 2022.
Winningham also received $722.7K in non-equity incentive plan, $1M in salary, $1.7M in stock awards and $5.1K in other compensation.
Rankings
In 2022, Rick E Winningham's compensation ranked 475th out of 5,499 executives tracked by ExecPay. In other words, Winningham earned more than 91.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 475 out of 5,499 | 91st |
Division Manufacturing | 197 out of 2,978 | 93rd |
Major group Chemicals And Allied Products | 54 out of 1,335 | 96th |
Industry group Drugs | 42 out of 1,238 | 97th |
Industry Pharmaceutical Preparations | 28 out of 892 | 97th |
Source: SEC filing on April 5, 2024.
Winningham's colleagues
We found one more compensation record of an executive who worked with Rick E Winningham at Theravance Biopharma in 2022.
2022
Richard Graham
Theravance Biopharma
Former Senior Vice President, Strategic Advisor R&D
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019